Frontiers in Immunology (Mar 2021)

IL-1 Family Antagonists in Mouse and Human Skin Inflammation

  • Praxedis Martin,
  • Praxedis Martin,
  • Jérémie D. Goldstein,
  • Jérémie D. Goldstein,
  • Loïc Mermoud,
  • Loïc Mermoud,
  • Alejandro Diaz-Barreiro,
  • Alejandro Diaz-Barreiro,
  • Gaby Palmer,
  • Gaby Palmer

DOI
https://doi.org/10.3389/fimmu.2021.652846
Journal volume & issue
Vol. 12

Abstract

Read online

Interleukin (IL)-1 family cytokines initiate inflammatory responses, and shape innate and adaptive immunity. They play important roles in host defense, but excessive immune activation can also lead to the development of chronic inflammatory diseases. Dysregulated IL-1 family signaling is observed in a variety of skin disorders. In particular, IL-1 family cytokines have been linked to the pathogenesis of psoriasis and atopic dermatitis. The biological activity of pro-inflammatory IL-1 family agonists is controlled by the natural receptor antagonists IL-1Ra and IL-36Ra, as well as by the regulatory cytokines IL-37 and IL-38. These four anti-inflammatory IL-1 family members are constitutively and highly expressed at steady state in the epidermis, where keratinocytes are a major producing cell type. In this review, we provide an overview of the current knowledge concerning their regulatory roles in skin biology and inflammation and their therapeutic potential in human inflammatory skin diseases. We further highlight some common misunderstandings and less well-known observations, which persist in the field despite recent extensive interest for these cytokines.

Keywords